COASTAL PHYSICIAN GROUP INC
NT 10-Q, 1998-05-15
SPECIALTY OUTPATIENT FACILITIES, NEC
Previous: RIDDELL SPORTS INC, 10-Q, 1998-05-15
Next: MARVEL ENTERTAINMENT GROUP INC, 10-Q, 1998-05-15






                          UNITED STATES                    OMB APPROVAL
                SECURITIES AND EXCHANGE COMMISSION        OMB
                      Washington, D.C. 20549              Num
                           FORM 12b-25                    ber
                                                         :    3235-0058
                                                         Exp
                                                         ire
                                                         s: May 31, 1997
                                                         Est
                                                         ima
                                                         ted
                                                         ave
                                                         rag
                                                         e
                                                         bur
                                                         den
                                                         hou
                                                         rs
                                                         per
                                                         res
                                                         pon
                                                         se        2.50
                   NOTIFICATION OF LATE FILING                SEC FILE NU
                                                             MBER
                                                            
                                                            001-
                                                            13460
(Check  CUSIP NUMBER
One):    Form 10-K        o     190495 10 1
Form 20-F       o Form 11-K       x Form 10-Q   o
Form N-SAR
     For Period Ended:   March 31, 1998
     [ ] Transition Report on Form 10-K
     [ ] Transition Report on Form 20-F
     [ ] Transition Report on Form 11-K
     [ ] Transition Report on Form 10-Q
     [ ] Transition Report on Form N-SAR
     For the Transition Period Ended:

Read Instruction (on back page) Before Preparing Form.  Please Print or T
ype.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:

 N/A

PART I - REGISTRANT INFORMATION

Coastal Physician Group, Inc.
Full Name of Registrant
N/A
Former Name if Applicable
2828 Croasdaile Drive
Address of Principal Executive Office (Street and Number)
Durham, North Carolina 27705
City, State and Zip Code

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed.  (Check box if appropriate)
    (a  The reasons described in reasonable detail in Part III of this
    )   form could not be eliminated without unreasonable  effort or
        expense;
    (b  The subject annual report, semi-annual report, transition report
    )   on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof,
        will be filed on or before the fifteenth calendar day following
        the prescribed due date; or the subject quarterly report or
        transition report on Form 10-Q, or portion thereof will be filed
        on or before the fifth calendar day following the prescribed due
        date; and
    (c  The accountant's statement or other exhibit required by Rule 12b-
    )   25(c) has been attached if applicable.

PART III - NARRATIVE
         The Registrant's executive officers that have
         responsibility for the preparation of reports
         under the Securities Exchange Act of 1934,
         have been engaged, and expect to continue to
         be engaged in, discussions with its lenders;
         and outside accountants and legal counsel on
         the resolution of a number of financing,
         accounting and legal issues. Due to the time
         and effort devoted to these discussions, the
         registrant is unable to file its quarterly
         report on Form 10-Q for the quarter ended
         March 31, 1998 within the prescribed time
         period.



PART IV - OTHER INFORMATION

(1)  Name and telephone number of person to contact in regard to this
notification

CHARLES F. KUONI, III
Executive Vice President and Chief Financial Officer                 (919)
383-0355
(Name)                                          (Area Code)
(Telephone Number)

(2)  Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter
period that the registrant was required to file such report(s) been filed?
If answer is no, identify reports(s).     x No

  Form 10-K for the year ended December 31, 1997.

(3)Is it anticipated that any significant change in results of operations 
  from the corresponding period for the last fiscal year will be reflected
  by the earnings statements to be included in the subject report or portion 
  thereof?                       x No

  If so, attach an explanation of the anticipated change, both
  narratively and quantitatively, and, if appropriate, state the
  reasons why a reasonable estimate of the results cannot be mades.   
                                                               


      
                    Coastal Physician Group, Inc.
               (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date  May 15, 1998                By /s/ CHARLES F. KUONI, III
                                     Charles F. Kuoni, III
                                     Executive Vice President and Chief
Financial Officer

INSTRUCTION:  The form may be signed by an executive officer of the
registrant or by any other duly authorized representative.  The name and
title of the person signing the form shall be typed or printed beneath the
signature.  If the statement is signed on behalf of the registrant by an
authorized representative (other than an executive officer), evidence of
the representative's authority to sign on behalf of the registrant shall
be filed with the form.

                                ATTENTION
    Intentional misstatements or omissions of fact constitute Federal
                Criminal Violations (See 18 U.S.C. 1001).

                           GENERAL INSTRUCTIONS

1.   This form is required by Rule 12b-25(17 CFR 240.12b-25) of the
  General Rules and Regulations under the Securities Exchange Act of 1934.

2.   One signed original and four conformed copies of this form and
  amendments thereto must be completed and filed with the Securities and
  Exchange Commission, Washington, D.C. 20549, in accordance with Rule 0-3
  of the General Rules and Regulations under the Act.  The information
  contained in or filed with the form will be made a matter of public record
  in the Commission files.

3.   A manually signed copy of the form and amendments thereto shall be
  filed with each national securities exchange on which any class of
  securities of the registrant is registered.

4.   Amendments to the notifications must also be filed on form 12b-25 but
  need not restate information that has been correctly furnished.  The form
  shall be clearly identified as an amended notification.

5.   Electronic Filers.  This form shall not be used by electronic filers
  unable to timely file a report solely due to electronic difficulties.
  Filers unable to submit a report within the time period prescribed due to
  difficulties in electronic filing should comply with either Rule 201 or
  Rule 202 of Regulation S-T (232.201 or 232.202 of this chapter) or apply
  for an adjustment in filing date pursuant to Rule 13(b) of Regulation S-T
  (232.13(b) of this SEC 1344 (6/94)  chapter).



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission